Xcout Intel
ACRIGEN BIOSCIENCES, INC.
Acrigen Biosciences, Inc. is a biotechnology company headquartered in California, United States. The firm is developing precision gene editing systems and delivery technologies to control CRISPR applications and provide advanced genetic medicines. Its research is conducted in collaboration with academic groups such as UCSF.
Subscribe to see ACRIGEN BIOSCIENCES, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ACRIGEN BIOSCIENCES, INC. at a glance
ACRIGEN BIOSCIENCES, INC. is a life sciences company headquartered in United States. It has raised at least $775,000 across the 3 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Seed, closed in September 2021.
ACRIGEN BIOSCIENCES, INC. funding rounds
At least $775,000 raised across the 3 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | Undisclosed | 1 named | |
| Seed VC | Undisclosed | 2 named | |
| SEC Form D filing | $775,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
ACRIGEN BIOSCIENCES, INC. competitors
A few of ACRIGEN BIOSCIENCES, INC.'s closest competitors — see the full list of competitors and alternatives →
Excision BioTherapeutics Inc. is a San Francisco-based clinical-stage biotechnology company focused on developing advanced gene editing therapeutics to treat infectious diseases.
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
Azalea Therapeutics is a biotechnology company headquartered in Berkeley, California. The company focuses on precision genome engineering directly inside the body with an initial emphasis on developing in vivo cancer immunotherapies.
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Epicrispr Biotechnologies is a pioneering therapeutics company dedicated to developing advanced genetic medicines. The organization focuses on scientific research, platforms, and clinical pipelines to treat serious diseases.
Get ACRIGEN BIOSCIENCES, INC.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ACRIGEN BIOSCIENCES, INC. in Xcout Intel
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access